🔎 Chart: SPY | TradingView 1H
At Wavervanir International LLC, our discretionary analysis on SPY (S&P 500 ETF) using SMC + ORB logic is signaling potential downside.
🔍 Market Structure:
CHoCH (Change of Character) confirmed after BOS (Break of Structure), suggesting buyer exhaustion.
Premium zone rejection with multiple failed attempts to reclaim the weak high.
Liquidity has shifted toward discount zones, aligning with volume imbalance and OB zones below.
🎯 Target Zones:
Immediate liquidity pool: 579.85
Demand block confluence: 575–565 zone
Deep mitigation OB: 560–557.50 zone
📊 Macro Context:
Bond volatility rising (MOVE index)
Fed holding rates steady, inflation stickiness remains
Liquidity tightening into quarter-end
🧠 Strategic View:
SPY looks poised to fill inefficiencies into the 575–565 range unless macro tailwinds emerge. Volume supports this as market seeks equilibrium post-premium rejection.
At Wavervanir International LLC, our discretionary analysis on SPY (S&P 500 ETF) using SMC + ORB logic is signaling potential downside.
🔍 Market Structure:
CHoCH (Change of Character) confirmed after BOS (Break of Structure), suggesting buyer exhaustion.
Premium zone rejection with multiple failed attempts to reclaim the weak high.
Liquidity has shifted toward discount zones, aligning with volume imbalance and OB zones below.
🎯 Target Zones:
Immediate liquidity pool: 579.85
Demand block confluence: 575–565 zone
Deep mitigation OB: 560–557.50 zone
📊 Macro Context:
Bond volatility rising (MOVE index)
Fed holding rates steady, inflation stickiness remains
Liquidity tightening into quarter-end
🧠 Strategic View:
SPY looks poised to fill inefficiencies into the 575–565 range unless macro tailwinds emerge. Volume supports this as market seeks equilibrium post-premium rejection.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.